Basics Stoke Therapeutics, Inc. IPO Date: June 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.13B Activated in VL: True Average Daily Range Avg Daily Range: $0.64 | 3.30% Avg Daily Range (30 D): $0.45 | 2.80% Avg Daily Range (90 D): $0.32 | 2.51% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .73M Avg Daily Volume (90 D): .62M Trade Size Avg Trade Size (Sh.): 77 Avg Trade Size (Sh.) (30 D): 64 Avg Trade Size (Sh.) (90 D): 62 Institutional Trades Total Inst.Trades: 1,137 Avg Inst. Trade: $1.82M Avg Inst. Trade (30 D): $1.95M Avg Inst. Trade (90 D): $1.34M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.44M Avg Closing Trade (30 D): $1.99M Avg Closing Trade (90 D): $1.34M Avg Closing Volume: 90.04K     News Jun 28, 2024 @ 4:01 PM A Closer Look at 5 Analyst Recommendations For Sto... Source: Benzinga Insights May 6, 2024 @ 3:01 PM Analyst Expectations For Stoke Therapeutics's Futu... Source: Benzinga Insights May 6, 2024 @ 12:05 PM Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T... Source: Zacks Equity Research Apr 29, 2024 @ 2:00 PM Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea... Source: Zacks Equity Research Apr 25, 2024 @ 2:01 PM Earnings Preview: Stoke Therapeutics, Inc. (STOK) ... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $.91 $-.4 $1.95 Diluted EPS $.86 $-.4 $1.9 Revenue $ 199.89M $ 13.82M $ 158.57M Gross Profit $ $ $ Net Income / Loss $ 52.48M $ -23.48M $ 112.88M Operating Income / Loss $ 40.28M $ -27.3M $ 111.24M Cost of Revenue $ $ $ Net Cash Flow $ -91.78M $ -173.35M $ 146.83M PE Ratio 23.93     Splits Jun 06, 2019:   10:99